Statins and cognitive functioning in the elderly: A population-based study

Journal of Alzheimer's Disease

Volumn 21, Issue 1, 2010, Pages 95-102

  Benito León, Juliín ^a,b   Louis, Elan D ^c,d,e   Vega, Saturio ^f   Bermejo Pareja, Félix ^a,b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^d Arévalo Health Center ^*  (United States)

^e NONE   (United States)

^f Health Center of Arévalo   (Spain)

Author keywords

Cognitive function; elderly; epidemiology; statins

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; SIMVASTATIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CHOLESTEROL BLOOD LEVEL; COGNITION; CONTROLLED STUDY; DEPRESSION; EDUCATIONAL STATUS; ELDERLY CARE; FEMALE; GROUPS BY AGE; HUMAN; INTELLIGENCE; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; VERBAL COMMUNICATION; DRUG EFFECTS; EXECUTIVE FUNCTION; FOLLOW UP; GERIATRIC ASSESSMENT; HEALTH CARE PLANNING; MENTAL HEALTH; NONPARAMETRIC TEST; RETROSPECTIVE STUDY; SPAIN; VASCULAR DISEASES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COGNITION; COMMUNITY HEALTH PLANNING; EXECUTIVE FUNCTION; FEMALE; FOLLOW-UP STUDIES; GERIATRIC ASSESSMENT; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTELLIGENCE; MALE; MEMORY; MENTAL STATUS SCHEDULE; NEUROPSYCHOLOGICAL TESTS; RETROSPECTIVE STUDIES; SPAIN; STATISTICS, NONPARAMETRIC; VASCULAR DISEASES;

EID: 77954989381     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-100180     Document Type: Article

References (40)

1. Hoglund K, Blennow K (2007) Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease. CNSDrugs 21, 449-462.
2. Xiong GL, Benson A, Doraiswamy PM (2005) Statins and cognition: what can we learn from existing randomized trials? CNS Spectr 10, 867-874.
3. Whitfield JF (2006) Can statins put the brakes on Alzheimer's disease? Expert Opin Investig Drugs 15, 1479-1485.
4. Rockwood K (2006) Epidemiological and clinical trials evidence about a preventive role for statins in Alzheimer's disease. Acta Neurol Scand Suppl 185, 71-77.
5. McGuinness B, Craig D, Bullock R, Passmore P (2009) Statins for the prevention of dementia. Cochrane Database Syst Rev 2, CD003160.
6. Yaffe K, Barrett-Connor E, Lin F, Grady D (2002) Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol 59, 378-384.
7. Parale GP, Baheti NN, Kulkarni PM, Panchal NV (2006) Effects ofatorvastatin on higher functions. Eur J Clin Pharmacol 62, 259-265.
8. Carlsson CM, Gleason CE, Hess TM, Moreland KA, Blazel HM, Koscik RL, Schreiber NT, Johnson SC, Atwood CS, Puglielli L, Hermann BP, McBride PE, Stein JH, Sager MA, Asthana S (2008) Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer's disease. J Alzheimers Dis 13, 187-197.
9. Bernick C, Katz R, Smith NL, Rapp S, Bhadelia R, Carlson M, Kuller L;Cardiovascular Health Study Collaborative Research Group (2005) Statins and cognitive function in the elderly: the Cardiovascular Health Study. Neurology 65, 1388-1394.
10. Szwast SJ, Hendrie HC, Lane KA, Gao S, Taylor SE, Unverzagt F, Murrell J, Deeg M, Ogunniyi A, Farlow MR, Hall KS (2007) Association of statin use with cognitive decline in elderly African Americans. Neurology 69, 1873-1880.
11. Solomon A, Kreholt I, Ngandu T, Wolozin B, Macdonald SW, Winblad B, Nissinen A, Tuomilehto J, Soininen H, Kivipelto M (2009) Serum total cholesterol, statins and cognition in non-demented elderly. Neurobiol Aging 30, 1006-1009.
12. Muldoon MF, Ryan CM, Sereika SM, Flory JD, Manuck SB (2004) Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adults. Am J Med 117, 823-829.
13. Santanello NC, Barber BL, Applegate WB, Elam J, Curtis C, Hunninghake DB, Gordon DJ (1997) Effect of pharmacologic lipid lowering on health-related quality of life in older persons: results from the Cholesterol Reduction in Seniors Program (CRISP) Pilot Study. J Am Geriatr Soc 45, 8-14.
14. Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Meinders AE, Norrie J, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG; PROSPER study group (2002) PROspective Study of Pravas-tatin in the Elderly at Risk. Pravastatin in elderly individuals at risk ofvascular disease (PROSPER): a randomized controlled trial. Lancet 360, 1623-1630.
15. Stein RA, Strickland TL (1998) A review of the neuropsycho-logical effects of commonly used prescription medications. Arch Clin Neuropsychol 13, 259-284.
16. Benito-Leon J, Bermejo-Pareja F, Rodriguez J, Molina JA, Gabriel R, Morales JM; Neurological Disorders in Central Spain (NEDICES) Study Group (2003) Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain. Mov Disord 18, 267-274. (Pubitemid 36410822)
17. Benito-Leon J, Bermejo-Pareja F, Morales-Gonzalez JM, Porta-Etessam J, Trincado R, Vega S, Louis ED; Neurological Disorders in Central Spain (NEDICES) Study Group (2004) Incidence of Parkinson disease and parkinsonism in three elderly populations of central Spain. Neurology 62, 734-741.
18. Benito-Leon J, Bermejo-Pareja F, Morales JM, Vega S, Molina JA (2003) Prevalence of essential tremor in three elderly populations of central Spain. Mov Disord 18, 389-394. (Pubitemid 36527279)
19. Benito-Leon J, Bermejo-Pareja F, Louis ED; Neurological Disorders in Central Spain (NEDICES) Study Group (2005) Incidence of essential tremor in three elderly populations of central Spain. Neurology 64, 1721-1725.
20. Diaz-Guzman J, Bermejo-Pareja F, Benito-Leon J, Vega S, Gabriel R, Medrano MJ; Neurological Disorders in Central Spain (NEDICES) Study Group (2008) Prevalence of stroke and transient ischemic attack in three elderly populations of central Spain. Neuroepidemiology 30, 247-253.
21. Bermejo-Pareja F, Benito-Leon J, Vega S, Olazaran J, de Toledo M, Diaz-Guzman J, Sanchez-Sanchez F, Morales-Gonzalez JM, Trincado R, Portera-Sanchez A, Roman GC (2009) Consistency of Clinical Diagnosis of Dementia in NEDICES: A Population-Based Longitudinal Study in Spain. J Geriatr Psychiatry Neurol 22, 246-255.
22. Bermejo-Pareja F, Benito-Leon J, Vega S, Medrano MJ, Roman GC; Neurological Disorders in Central Spain (NEDICES) Study Group (2008) Incidence and subtypes of dementia in three elderly populations of central Spain. J Neurol Sci 264, 63-72. (Pubitemid 350193244)
23. Morales JM, Bermejo FP, Benito-Leon J, Rivera-Navarro J, Trincado R, Gabriel S R, Vega S; NEDICES Study Group (2004) Methods and demographic findings ofthe baseline survey of the NEDICES cohort: a door-to-door survey of neurological disorders in three communities from Central Spain. Public Health 118, 426-433.
24. Bermejo-Pareja F, Benito-Leon J, Vega-Q S, Diaz-Guzman J, Rivera-Navarro J, Molina JA, Olazaran-Rodriguez J, Morales-Gonzalez JM (2008) La cohorte de ancianos NEDICES. Metodologia y principales hallazgos neurologicos. Rev Neurol 46, 416-423.
25. Vega S, Benito-Leon J, Bermejo-Pareja F, Medrano MJ, Vega-Valderrama LM, Rodriguez C, Louis ED (2010) Several factors influenced attrition in a population-based elderly cohort: Neurological disorders in Central Spain Study. J Clin Epidemiol 63, 215-222.
26. Zunzunegui MV, Gutierrez Cuadra P, Beland F, Del Ser T Wolfson C (2000) Development of simple cognitive functioi measures in a community dwelling population of elderly i Spain. Int J Geriatr Psychiatry 15, 130-140.
27. De Yebenes MJ, Otero A, Zunzunegui MV, Rodriguez-Lasc A, Sanchez-Sanchez F, Del Ser T (2003) Validation of a shor cognitive tool for the screening of dementia in elderly peopl with low educational level. Int J Geriatr Psychiatry 18, 925 936.
28. Baldereschi M, Meneghini F, Quiroga P, Albala C, Mamo J Muscat P (2004) Cognitive versus functional screening fo dementia across different countries: cross-cultural validatio of the Mini-Mental State Examination (MMSE) and the Pf effer activities questionnaire (PFAQ) against the standardise clinical diagnosis of dementia. Neurology 44(Suppl 2), A365
29. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-menta state". A practical method for grading the cognitive state o patients for the clinician. JPsychiatr Res 12, 189-198.
30. Olazaran J, Trincado R, Bermejo F, Benito-Leon J, Diaz J. Vega S (2004) Selective memory impairment on an adaptec Mini-Mental State Examination increases risk of future de mentia. Int J Geriatr Psychiatry 19, 1173-1180.
31. B. (Pubitemid 43958543)
32. Bermejo-Pareja F, Louis ED, Benito-Leon J; Neurological Disorders in Central Spain (NEDICES) Study Group (2007 Risk of incident dementia in essential tremor: a population based study. Mov Disord 22, 1573-1580. (Pubitemid 47477918)
33. Benito-Leon J, Bermejo-Pareja F, Vega S, Louis ED (2009) Total daily sleep duration and the risk ofdementia: a prospec tive population-based study. Eur J Neurol 16, 990-997.
34. Greenlief CL, Margolis RB, Erker GJ (1985) Application o: the Trail Making Test in differentiating neuropsychologica impairment of elderly persons. Percept Mot Skills 61, 1283 1289.
35. Rosen WG (1980) Verbal fluency in aging and dementia. Clin Neuropsychol 2, 135-146.
36. Wechsler D (1987). Wechsler Memory Scale-Revised. Sat Antonio, TX: The Psychological Corporation
37. Del Ser T, Gonzalez-Montalvo JI, Martinez-Espinosa S. Delgado-Villapalos C, Bermejo F (1997) Estimation of pre morbid intelligence in Spanish people with the Word Accen tuation Test and its application to the diagnosis of dementia Brain Cogn 33, 343-356.
38. West R, Beeri MS, Schmeidler J, Hannigan CM, Angelo G Grossman HT, Rosendorff C, Silverman JM (2008) Bette memory functioning associated with higher total and low density lipoprotein cholesterol levels in very elderly subject without the apolipoprotein e4 allele. Am J Geriatr Psychiatr 16, 781-785.
39. Mahoney J, Drinka TJ, Abler R, Gunter-Hunt G, Matthews C, Gravenstein S, Carnes M (1994) Screening for depression single question versus GDS. J Am Geriatr Soc 42, 1006-1008
40. Louis ED, Benito-Leon J, Bermejo-Pareja F; Neurologica Disorders in Central Spain (NEDICES) Study Group (2007 Self-reported depression and anti-depressant medication us in essential tremor: cross-sectional and prospective analyse in a population-based study. Eur J Neurol 14, 1138-1146.